Aspirin Combined With Clopidogrel Versus Intravenous Alteplase for Acute Minor Stroke

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2023
An open-label, blinded endpoint, randomized controlled trial that includes patients diagnosed with non-disabling, non-large vessel occlusion, acute minor stroke within 4.5 hours of onset. Eligible participants would be randomly assigned to the thrombolysis group (intravenous alteplase) and the dual antiplatelet group (oral aspirin plus clopidogrel). The primary outcome is the proportion of the excellent functional outcome (modified Rankin scale 0-1) at 90 days.
Epistemonikos ID: 27c5dfe17a70e5f7152b2b1f9f4d89b0553c965c
First added on: Feb 19, 2024